A detailed history of Td Asset Management Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 82,090 shares of IDYA stock, worth $1.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
82,090
Previous 116,690 29.65%
Holding current value
$1.9 Million
Previous $4.1 Million 36.52%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$30.37 - $43.05 $1.05 Million - $1.49 Million
-34,600 Reduced 29.65%
82,090 $2.6 Million
Q2 2024

Aug 02, 2024

SELL
$34.37 - $43.46 $2.24 Million - $2.83 Million
-65,200 Reduced 35.85%
116,690 $4.1 Million
Q1 2024

May 08, 2024

BUY
$34.2 - $47.13 $1.51 Million - $2.08 Million
44,200 Added 32.1%
181,890 $7.98 Million
Q4 2023

Feb 12, 2024

BUY
$24.59 - $35.83 $590,996 - $861,138
24,034 Added 21.15%
137,690 $4.9 Million
Q3 2023

Oct 27, 2023

BUY
$21.07 - $29.77 $1.61 Million - $2.28 Million
76,528 Added 206.12%
113,656 $3.07 Million
Q2 2023

Aug 09, 2023

BUY
$13.33 - $25.53 $494,916 - $947,877
37,128 New
37,128 $872,000
Q2 2022

Aug 04, 2022

SELL
$8.28 - $13.88 $168,912 - $283,152
-20,400 Reduced 58.45%
14,502 $200,000
Q1 2022

May 10, 2022

SELL
$11.18 - $24.02 $451,672 - $970,408
-40,400 Reduced 53.65%
34,902 $391,000
Q4 2021

Feb 10, 2022

BUY
$20.95 - $26.88 $182,265 - $233,856
8,700 Added 13.06%
75,302 $1.78 Million
Q3 2021

Nov 09, 2021

BUY
$17.26 - $27.08 $151,888 - $238,303
8,800 Added 15.22%
66,602 $1.7 Million
Q2 2021

Aug 11, 2021

BUY
$17.76 - $24.83 $353,370 - $494,042
19,897 Added 52.49%
57,802 $1.42 Million
Q1 2021

May 14, 2021

BUY
$13.48 - $23.77 $194,179 - $342,406
14,405 Added 61.3%
37,905 $891,000
Q4 2020

Feb 16, 2021

BUY
$12.17 - $17.52 $285,995 - $411,720
23,500 New
23,500 $329,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.11B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.